A Study of Patients With AIDS Syndrome
NCT00001120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2008-09-12
Summary
The purpose of this study is to find out why cancers develop in HIV-positive patients.
Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include certain chemicals, viruses, and perhaps even anti-HIV drugs. Doctors would like to find out which risk factors are most important and how they relate to cancer in AIDS patients.
Conditions
- Sarcoma, Kaposi
- Lymphoma, Non-Hodgkin
- HIV Infections
- Lymphoma, AIDS-Related
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
David A. Wohl · Univ of North Carolina
-
Ann C. Collier · Univ of Washington
-
William G. Powderly
-
Charles S. Rabkin
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi
NCT03160183 ·Status: COMPLETED
-
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
NCT00006518 ·Status: RECRUITING
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003863 ·Status: COMPLETED
-
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00026910 ·Status: COMPLETED
-
Head and Neck Cancer Screening and Serum Repository
NCT00592371 ·Status: COMPLETED
-
Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation
NCT02132858 ·Status: COMPLETED
-
Molecular Biology of Anal Cancer in HIV-Positive Patients
NCT00952874 ·Status: COMPLETED
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598 ·Status: COMPLETED
-
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
NCT05708599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma
NCT02823327 ·Status: TERMINATED
-
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
NCT07327489 ·Status: RECRUITING
-
A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
NCT02857608 ·Status: WITHDRAWN ·Phase: PHASE2
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
NCT00918008 ·Status: TERMINATED
-
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
NCT00341146 ·Status: COMPLETED
-
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
NCT01623856 ·Status: COMPLETED
-
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
NCT00001503 ·Status: COMPLETED
-
Studying Gene Expression in Samples From Younger Patients With Neuroblastoma
NCT01553448 ·Status: COMPLETED
-
Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma
NCT01585376 ·Status: COMPLETED
-
Study of Kidney Tumors in Younger Patients
NCT00898365 ·Status: COMPLETED
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073 ·Status: RECRUITING
-
Study of Proteins in Head and Neck Cancer Cells
NCT00896948 ·Status: COMPLETED
-
S1204, Viral Screening in Newly Diagnosed Cancer Patients
NCT01946516 ·Status: COMPLETED
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING